<DOC>
	<DOCNO>NCT02997033</DOCNO>
	<brief_summary>Population-based , longitudinal cohort study design evaluate change bone mineral density , bone geometry , body composition , parameter reflect muscle force , sex steroid status healthy young men , well interaction , period +-10 year .</brief_summary>
	<brief_title>SIBlos EXtension Study ( SIBEX )</brief_title>
	<detailed_description>Osteoporosis common disorder affect sex , lifetime risk sustain fragility fracture age 50 estimate 40-50 % woman 13-22 % men . The age-specific fracture risk men half woman , result part achievement high bone mass men , particular large bone size growth . Bone size , mass strength elderly depend accrual loss bone time . Not epidemiological also potentially preventive viewpoint , important understand determinant component identify risk protective factor bone accrual loss life . Hormonal status men , e.g . gonadal thyroid hormone level , wide range effect different body compartment . For thyroid gonadal steroid level , exist wide inter-individual variation , even among healthy young men . Up till , clear whether variation represent true difference hormonal exposure whether represent inter-individual variation hormonal responsiveness . Since prevalence thyroid disorder age- obesity-associated hypogonadism rather high , relevant ass determinant clinical correlate between-subject variation sex steroid thyroid hormone status . Our research department therefore undertook cross-sectional , population-based study healthy men age 25-45 year aim investigate determinant peak bone mass between-subject variation gonadal thyroid hormone status ( SIBLOS study ) . In total , 1114 men recruit 2002 till 2009 . Herein , focus genetic determinant ( SNPs , single nucleotide polymorphism ) contribute between-subject difference bone mass , well interrelationship body composition , bone mass , density size , lifestyle hormonal status ( sex steroid , thyroid hormone ) . In addition , assess determinant sex steroid thyroid hormone status , focus genetic polymorphism , body composition lifestyle factor . The investigation SIBLOS study perform use state-of-the-art technology dual-energy X-ray absorptiometry peripheral quantitative compute tomography evaluate bone , muscle body composition parameter ; assessment anthropometric parameter well-trained personnel ; validate questionnaire regard lifestyle , physical activity calcium intake ; use liquid gas chromatography / mass spectrometry assess serum hormonal level ; use KASPar technology genotyping high-yield DNA extraction procedure . From cross-sectional study , example , follow result emerge : - Estradiol seem main sex steroid associate bone mineral density bone geometry , whereas testosterone weakly associate parameter reflect muscle strength . In addition , serum estradiol level might modulate impact physical activity bone size tibia . - Smokers present high prevalence previous fracture , especially start smoke young age . This could partly explain observation lower bone mineral density thinner cortex smoker . - Physical activity , muscle mass parameter reflect muscle force strongly associate bone size ; whereas fat mass display inverse association bone mass size . - Birth weight associate high testosterone level adult age ; addition weight gain higher/lower expect life associate lower/higher testosterone level adult age . - Serum level sex-hormone binding globulin positively associate bone size adult men . - Higher serum thyroid hormone level associate low bone mineral density cortical bone area . - A less favorable body composition ( high fat lower muscle mass ) insulin resistance associate high serum thyroid hormone concentration . - Serum thyroid hormone level influence SNPs monocarboxylate transporter ( MCT ) -8 gene . - Testosterone serum level associate genetic polymorphism gene encode androgen receptor sex-hormone binding globulin . Our initial analysis SIBLOS population cross-sectional . Although revealing , , , cross-sectional study limitation , mainly association allow conclusion direction causality . To add prospective element acquire data investigate change time , plan perform longitudinal follow-up study population ( SIBEX - SIBlos EXtension study ) , mean time knowledge increase new question emerge , additional investigation intend . The general aim follow-up study include evaluation change bone mineral density , bone geometry , body composition , parameter reflect muscle force sex steroid status healthy young men , +-10 year initial evaluation SIBLOS cohort .</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<criteria>Full participation first SIBLOS study Informed consent Unwillingness inability participate Medication disease know affect bone metabolism , body composition and/or sex steroid metabolism : malignancy ( previous current ) systemic disease ( autoimmune rheumatoid pathology , ankylose spondylitis ) previous current systemic use glucocorticoid 3 month , irrespective dose use glucocorticoid injection previous 3 month use inhalation glucocorticoid 500 µg / day previous current thyroxin therapy ( Graves disease , thyroidectomy ) current insulin use diabetes mellitus previous current ( anti ) androgen treatment treat hypogonadism previous current antiepileptic drug ( phenytoin , valproate , carbamazepine , oxcarbazepine/carbamazepine , primidone ) previous current hyperthyroidism previous current hyperparathyroidism serum calcaemia &lt; 8.5 &gt; 11 mg/dL hypocalcaemia ( correct albumin , confirm 2 measurement ) cystic fibrosis orchidectomy irrespective underlying cause history immobilisation &gt; 3 month immobilisation &gt; 4 week within previous 6 month previous current history eat disorder serum creatinine &gt; 2 mg % ( estimate creatinine clearance &lt; 35 mL/min ) know disease affect growth , collagen , bone development body composition ( OI , otosclerosis , AIDS , ... ) previous current gastrointestinal malabsorption ( gastrectomy , Crohn 's disease , ulcerative colitis , coeliac disease , haemochromatosis ) alcoholism ( &gt; 42 unit per week ) organ transplant recipient previous current treatment osteoporosis previous treatment cryptorchidism irrespective age current varicocoele treatment varicocoele age 25 year ( exclusion testosterone level blood normal ) BMI &gt; 42.3 kg/m²</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Bone</keyword>
	<keyword>Sex steroid</keyword>
	<keyword>Body composition</keyword>
	<keyword>Men</keyword>
</DOC>